Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
calcitriol, Quantity: 0.25 microgram
Arrotex Pharmaceuticals Pty Ltd
Calcitriol
Capsule, soft
Excipient Ingredients: fractionated coconut oil; butylated hydroxyanisole; butylated hydroxytoluene; Gelatin; glycerol; sorbitol solution (70 per cent) (non-crystallising); purified water; iron oxide red; iron oxide yellow; titanium dioxide
Oral
100 capsules
(S4) Prescription Only Medicine
Calcitriol is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture.,Calcitriol is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss.,Calcitriol is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.
Visual Identification: Red coloured, oval soft gelatin capsules containing a clear oily liquid.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2015-12-01
_ _ _CALITROL capsules – Consumer Medicine Information _ _ _ _CALITROL CMI _ _ _ _ _ _Page 1 _ CALITROL CAPSULES _Calcitriol _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about CALITROL capsules. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking CALITROL capsules against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT CALITROL IS USED FOR CALITROL contains the active ingredient calcitriol, one of the naturally occurring and biologically active forms of Vitamin D. Calcitriol acts in the body in a similar manner to Vitamin D. CALITROL is used to treat people with osteoporosis, a disease where the bones of the body weaken, and in the prevention of osteoporosis in people taking oral corticosteroids. CALITROL capsules are also prescribed for patients who have low blood calcium levels due to osteodystrophy (a type of bone disease), hypoparathyroidism (a condition where the parathyroid glands have decreased function) and rickets. CALITROL increases calcium absorption in the intestine and stimulates healthy bone growth. There are many different types of medicines used to treat bone conditions. CALITROL belongs to a group of medicines known as vitamin D compounds. Your doctor may have prescribed CALITROL for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS WHY CALITROL HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor's prescription. CALITROL is not addictive. BEFORE YOU TAKE CALITROL _ _ _WHEN YOU MUST NOT TAKE _ _IT _ _ _ DO NOT TAKE CALITROL IF: • YOU HAVE HAD AN ALLERGIC REACTION TO CALITROL, CALCITRIOL OR ANY INGREDIENTS LISTED IN THE INGREDIENTS SECTION OF THIS LEAFLET • YOU HAVE HIGH BLOOD CALCIUM LEVELS (HYPERCALCAE Preberite celoten dokument
1 AUSTRALIAN PRODUCT INFORMATION – CALITROL ( CALCITRIOL 0.25 MICROGRAM ) CAPSULES 1 NAME OF THE MEDICINE The name of the medicine is Calcitriol. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Calcitriol is available as soft gelatin capsules containing 0.25 micrograms of calcitriol. Calcitriol is a white, crystalline compound, which occurs naturally in humans. It is soluble in organic solvents but practically insoluble in water. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM CALITROL 0.25 microgram is supplied as soft red coloured, oval soft gelatine capsule containing a clear oily liquid. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS CALITROL is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture. CALITROL is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. CALITROL is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets. 4.2 D OSE AND METHOD OF ADMINISTRATION The optimal daily dose of CALITROL must be carefully determined for each patient and indication. Dosage optimisation should be accompanied by regular monitoring of serum calcium concentration. If hypercalcemia occurs, the drug should be immediately discontinued until normocalcemia ensues. ADULTS: OSTEOPOROSIS: _ESTABLISHED OSTEOPOROSIS: _The recommended dose of CALITROL is 0.25 microgram twice daily. If a satisfactory response is not obtained with this dose, it may be increased, with regular serum calcium monitoring, to a maximum of 0.5 microgram twice daily. This increased dose should rarely be necessary. 2 _CORTICOSTEROID-INDUCED OSTEOPOROSIS: _The recommended dose is 0.25 microgram twice daily for steroid doses equivalent to < 10 mg/day of oral prednisone increasing to 0. Preberite celoten dokument